Literature DB >> 32408338

Pathogenesis and transmission of SARS-CoV-2 in golden hamsters.

Sin Fun Sia1, Li-Meng Yan1, Alex W H Chin1, Kevin Fung2, Ka-Tim Choy1, Alvina Y L Wong1, Prathanporn Kaewpreedee1, Ranawaka A P M Perera1, Leo L M Poon1, John M Nicholls2, Malik Peiris1, Hui-Ling Yen3.   

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus with high nucleotide identity to SARS-CoV and to SARS-related coronaviruses that have been detected in horseshoe bats, has spread across the world and had a global effect on healthcare systems and economies1,2. A suitable small animal model is needed to support the development of vaccines and therapies. Here we report the pathogenesis and transmissibility of SARS-CoV-2 in golden (Syrian) hamsters (Mesocricetus auratus). Immunohistochemistry assay demonstrated the presence of viral antigens in nasal mucosa, bronchial epithelial cells and areas of lung consolidation on days 2 and 5 after inoculation with SARS-CoV-2, followed by rapid viral clearance and pneumocyte hyperplasia at 7 days after inoculation. We also found viral antigens in epithelial cells of the duodenum, and detected viral RNA in faeces. Notably, SARS-CoV-2 was transmitted efficiently from inoculated hamsters to naive hamsters by direct contact and via aerosols. Transmission via fomites in soiled cages was not as efficient. Although viral RNA was continuously detected in the nasal washes of inoculated hamsters for 14 days, the communicable period was short and correlated with the detection of infectious virus but not viral RNA. Inoculated and naturally infected hamsters showed apparent weight loss on days 6-7 post-inoculation or post-contact; all hamsters returned to their original weight within 14 days and developed neutralizing antibodies. Our results suggest that features associated with SARS-CoV-2 infection in golden hamsters resemble those found in humans with mild SARS-CoV-2 infections.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32408338      PMCID: PMC7394720          DOI: 10.1038/s41586-020-2342-5

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  2 in total

1.  Syrian Hamster as an Animal Model for the Study of Human Influenza Virus Infection.

Authors:  Kiyoko Iwatsuki-Horimoto; Noriko Nakajima; Yurie Ichiko; Yuko Sakai-Tagawa; Takeshi Noda; Hideki Hasegawa; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2018-01-30       Impact factor: 5.103

2.  Mice transgenic for human angiotensin-converting enzyme 2 provide a model for SARS coronavirus infection.

Authors:  Xiu-Hong Yang; Wei Deng; Zan Tong; Yan-Xia Liu; Lian-Feng Zhang; Hua Zhu; Hong Gao; Lan Huang; Ya-Li Liu; Chun-Mei Ma; Yan-Feng Xu; Ming-Xiao Ding; Hong-Kui Deng; Chuan Qin
Journal:  Comp Med       Date:  2007-10       Impact factor: 0.982

  2 in total
  457 in total

1.  Retail store customer flow and COVID-19 transmission.

Authors:  Robert A Shumsky; Laurens Debo; Rebecca M Lebeaux; Quang P Nguyen; Anne G Hoen
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-16       Impact factor: 11.205

2.  Monitoring of SARS-CoV-2 infection in mustelids.

Authors:  Anette Boklund; Christian Gortázar; Paolo Pasquali; Helen Roberts; Søren Saxmose Nielsen; Karl Stahl; Arjan Stegeman; Francesca Baldinelli; Alessandro Broglia; Yves Van Der Stede; Cornelia Adlhoch; Erik Alm; Angeliki Melidou; Grazina Mirinaviciute
Journal:  EFSA J       Date:  2021-03-03

3.  Update on animal models for COVID-19 research.

Authors:  Simon J Cleary; Mélia Magnen; Mark R Looney; Clive P Page
Journal:  Br J Pharmacol       Date:  2020-11-02       Impact factor: 8.739

Review 4.  SARS-CoV-2 vaccine candidates in rapid development.

Authors:  Lifeng Li; Pengbo Guo; Xiaoman Zhang; Zhidan Yu; Wancun Zhang; Huiqing Sun
Journal:  Hum Vaccin Immunother       Date:  2020-10-29       Impact factor: 3.452

Review 5.  Targeting the renin-angiotensin signaling pathway in COVID-19: Unanswered questions, opportunities, and challenges.

Authors:  Krishna Sriram; Rohit Loomba; Paul A Insel
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-17       Impact factor: 11.205

Review 6.  SARS-CoV-2 vaccines in development.

Authors:  Florian Krammer
Journal:  Nature       Date:  2020-09-23       Impact factor: 49.962

Review 7.  COVID-19 false dichotomies and a comprehensive review of the evidence regarding public health, COVID-19 symptomatology, SARS-CoV-2 transmission, mask wearing, and reinfection.

Authors:  Kevin Escandón; Angela L Rasmussen; Isaac I Bogoch; Eleanor J Murray; Karina Escandón; Saskia V Popescu; Jason Kindrachuk
Journal:  BMC Infect Dis       Date:  2021-07-27       Impact factor: 3.090

8.  Femtomolar SARS-CoV-2 Antigen Detection Using the Microbubbling Digital Assay with Smartphone Readout Enables Antigen Burden Quantitation and Tracking.

Authors:  Hui Chen; Zhao Li; Sheng Feng; Melissa Richard-Greenblatt; Emily Hutson; Stefen Andrianus; Laurel J Glaser; Kyle G Rodino; Jianing Qian; Dinesh Jayaraman; Ronald G Collman; Abigail Glascock; Frederic D Bushman; Jae Seung Lee; Sara Cherry; Alejandra Fausto; Susan R Weiss; Hyun Koo; Patricia M Corby; Alfonso Oceguera; Una O'Doherty; Alfred L Garfall; Dan T Vogl; Edward A Stadtmauer; Ping Wang
Journal:  Clin Chem       Date:  2021-12-30       Impact factor: 8.327

9.  TLR3-Activated Monocyte-Derived Dendritic Cells Trigger Progression from Acute Viral Infection to Chronic Disease in the Lung.

Authors:  Xinyu Wang; Kangyun Wu; Shamus P Keeler; Dailing Mao; Eugene V Agapov; Yong Zhang; Michael J Holtzman
Journal:  J Immunol       Date:  2021-01-29       Impact factor: 5.422

Review 10.  Animal models for COVID-19.

Authors:  César Muñoz-Fontela; William E Dowling; Simon G P Funnell; Pierre-S Gsell; A Ximena Riveros-Balta; Randy A Albrecht; Hanne Andersen; Ralph S Baric; Miles W Carroll; Marco Cavaleri; Chuan Qin; Ian Crozier; Kai Dallmeier; Leon de Waal; Emmie de Wit; Leen Delang; Erik Dohm; W Paul Duprex; Darryl Falzarano; Courtney L Finch; Matthew B Frieman; Barney S Graham; Lisa E Gralinski; Kate Guilfoyle; Bart L Haagmans; Geraldine A Hamilton; Amy L Hartman; Sander Herfst; Suzanne J F Kaptein; William B Klimstra; Ivana Knezevic; Philip R Krause; Jens H Kuhn; Roger Le Grand; Mark G Lewis; Wen-Chun Liu; Pauline Maisonnasse; Anita K McElroy; Vincent Munster; Nadia Oreshkova; Angela L Rasmussen; Joana Rocha-Pereira; Barry Rockx; Estefanía Rodríguez; Thomas F Rogers; Francisco J Salguero; Michael Schotsaert; Koert J Stittelaar; Hendrik Jan Thibaut; Chien-Te Tseng; Júlia Vergara-Alert; Martin Beer; Trevor Brasel; Jasper F W Chan; Adolfo García-Sastre; Johan Neyts; Stanley Perlman; Douglas S Reed; Juergen A Richt; Chad J Roy; Joaquim Segalés; Seshadri S Vasan; Ana María Henao-Restrepo; Dan H Barouch
Journal:  Nature       Date:  2020-09-23       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.